These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 9430227

  • 1. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.
    Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L.
    Immunity; 1997 Dec; 7(6):821-30. PubMed ID: 9430227
    [Abstract] [Full Text] [Related]

  • 2. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A.
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [Abstract] [Full Text] [Related]

  • 3. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N, Hughes M, MacFarlane M, Cohen GM.
    J Biol Chem; 2003 Jul 11; 278(28):25534-41. PubMed ID: 12721308
    [Abstract] [Full Text] [Related]

  • 4. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.
    Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J.
    Immunity; 1997 Dec 11; 7(6):831-6. PubMed ID: 9430228
    [Abstract] [Full Text] [Related]

  • 5. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.
    Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM.
    Science; 1996 Nov 08; 274(5289):990-2. PubMed ID: 8875942
    [Abstract] [Full Text] [Related]

  • 6. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation.
    Wang Y, Wu TR, Cai S, Welte T, Chin YE.
    Mol Cell Biol; 2000 Jul 08; 20(13):4505-12. PubMed ID: 10848577
    [Abstract] [Full Text] [Related]

  • 7. The receptor for the cytotoxic ligand TRAIL.
    Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM.
    Science; 1997 Apr 04; 276(5309):111-3. PubMed ID: 9082980
    [Abstract] [Full Text] [Related]

  • 8. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL.
    MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES.
    J Biol Chem; 1997 Oct 10; 272(41):25417-20. PubMed ID: 9325248
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P.
    J Biol Chem; 2000 Aug 11; 275(32):24357-66. PubMed ID: 10823821
    [Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N, Gibson SB.
    Apoptosis; 2002 Oct 11; 7(5):413-20. PubMed ID: 12207174
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD.
    Kidney Int; 2000 Oct 11; 58(4):1481-91. PubMed ID: 11012883
    [Abstract] [Full Text] [Related]

  • 12. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis.
    Hu S, Vincenz C, Buller M, Dixit VM.
    J Biol Chem; 1997 Apr 11; 272(15):9621-4. PubMed ID: 9092488
    [Abstract] [Full Text] [Related]

  • 13. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A, Lam A, Datta R, Srivastava RK.
    Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.
    Lin Y, Devin A, Rodriguez Y, Liu ZG.
    Genes Dev; 1999 Oct 01; 13(19):2514-26. PubMed ID: 10521396
    [Abstract] [Full Text] [Related]

  • 18. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
    Thomas LR, Henson A, Reed JC, Salsbury FR, Thorburn A.
    J Biol Chem; 2004 Jul 30; 279(31):32780-5. PubMed ID: 15173180
    [Abstract] [Full Text] [Related]

  • 19. Activation of the NF-kappaB pathway by caspase 8 and its homologs.
    Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L.
    Oncogene; 2000 Sep 14; 19(39):4451-60. PubMed ID: 11002417
    [Abstract] [Full Text] [Related]

  • 20. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
    Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M, Scheurich P.
    Curr Biol; 1998 Jan 15; 8(2):113-6. PubMed ID: 9427646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.